Using the i-FILL® Micro pump has supported our rapid company growth and enabled us to package our product to meet demand in both the US and our new European distribution center
Westminster, MD (PRWEB) December 18, 2012
Intellitech, leading provider of liquid filling equipment for biotech (ELISA kit, reagent, cell therapy, biologics) and pharmaceutical is delivering unmatched performance with the i-FILL® Micro, the latest addition to the i-FILL® family of precision filling equipment.
In 2012, Life Diagnostics, Inc., developed nine new clinical research kits which required a versatile filling solution. The company President, noted “Using the i-FILL® Micro pump has supported our rapid company growth and enabled us to package our product to meet demand in both the US and our new European distribution center.”
The i-FILL® Micro’s disposable fluid path and unmatched dispense accuracy combine to save time and money by eliminating cleaning protocols and reducing product waste. “We’ve received data from customers who have validated our pumps. They are excited to share the better-than-expected statistical capability data. We are committed to setting a new standard of performance excellence in filling for our customers.” commented Intellitech president Barbara Biller.
Intellitech, Inc. products include the modular i-FILL® family of precision pumps (rated "Superior" for dispensing accuracy & repeatability), i-CAP® package closure systems, intelliFILLER™ line of liquid fill/finish solutions and intelliFLEX® wash down conveyors for the bio-tech, pharmaceutical and specialty chemical industries. With over 80 installations worldwide since 2002, our products are satisfying customers through their ease of use, expandability and reliable performance. To learn more about Intellitech’s family of products, call 866-434-5548 or visit us at http://www.intellitech-inc.com.
ABOUT LIFE DIAGNOSTICS, INC.
Life Diagnostics, Inc. develops and manufactures ELISA kits and purified biomarkers for preclinical research focusing on cardiovascular, acute phase, immunotoxicity and immunology biomarkers. Additionally, because of the increasing research surrounding PEGylated biologics, we have developed several anti-PEG monoclonal antibodies and an ELISA kit for detection of free PEG and PEGylated proteins.